Skip to main content
. 2022 Jul 20;29(60):89954–89968. doi: 10.1007/s11356-022-21932-1

Table 2.

Effect of CCM treatment on lesion scoring of the cochlear structures of the ear of GEN or NaS administered rats

Lesions  Control OO CCM GEN NaS CCM+GEN CCM+NaS
Spiral ganglion
Necrotic neurons 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 3.17* ± 0.26 3.50* ± 0.29 1.67*# ± 0.36 1.83*# ± 0.51
Vacuolation 0.17 ± 0.14 0.17 ± 0.14 0.33 ± 0.18 2.67* ± 0.18 1.17* ± 0.34 1.17*# ± 0.26 0.83 ± 0.26
Decreased number of spiral ganglion cells 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 2.17* ± 0.34 1.83* ± 0.26 1.17*# ± 0.14 1.00*# ± 0.22
Stria vascularis
Cracking of epithelium 0.67 ± 0.28 0.00 ± 0.00 0.00 ± 0.00 0.83* ± 0.26 2.83* ± 0.34 0.50 ± 0.29 1.17*# ± 0.40
Congested capillaries 0.00 ± 0.00 0.67 ± 0.18 0.67 ± 0.18 1.00 ± 0.00 2.05* ± 0.34 1.00 ± 0.31 1.50* ± 0.29
Organ of Corti
Loss of hair cells 0.00±0.00 0.00 ± 0.00 0.00 ± 0.00 4.17* ± 0.34 2.83* ± 0.34 3.00*# ± 0.22 1.83*# ± 0.26

Values are represented as the mean ± SE. n = 10 replicates/treatment

OO olive oil

*Significantly different compared to the control group (i.e., GEN, NaS, GEN+CCM, or CCM+NaS vs. control group) at P < 0.05

#Significantly different from the respective drug only treated group (i.e., CCM+GEN vs. GEN and CCM+NaS vs. NaS) compared to the control group at P < 0.05